FEG
AMGN icon

Fund Evaluation Group’s Amgen AMGN Stock Holding History

Fund Evaluation Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,291
Closed -$1.72M – 27
2018
Q3 		$1.72M Sell
8,291
-1,124
-12% -$222K 0.28% 35
2018
Q2 		$1.74M Hold
9,415
– – 0.28% 39
2018
Q1 		$1.6M Buy
+9,415
New +$1.73M 0.18% 44

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fund Evaluation Group's AMGN Position: Q4 2018 in Review

Fund Evaluation Group sold out of Amgen (AMGN) in Q4 2018, closing a stake of 8,291 shares — an estimated $1.72M sold.

Fund Evaluation Group first reported a position in AMGN in Q1 2018 and held it in 3 quarters. The position peaked at $1.74M in Q2 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Fund Evaluation Group reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • Fund Evaluation Group sold 8,291 Amgen shares in Q4 2018, an estimated $1.72M.
  • Fund Evaluation Group first reported a position in Amgen in Q1 2018 and held it in 3 quarters.
  • Fund Evaluation Group's Amgen position peaked at $1.74M in Q2 2018.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Fund Evaluation Group's 13F filing for Q4 2018, filed 12 Feb 2019.